Kevin J Contrera
Overview
Explore the profile of Kevin J Contrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Zandberg D, Kulkarni A, Chiosea S, Santos P, Isett B, et al.
Cancer Cell
. 2025 Mar;
PMID: 40086437
We leverage a clinical trial (NCT04080804) that compared neoadjuvant anti-PD-1, anti-PD-1+CTLA-4, and anti-PD-1+LAG-3 therapies in head and neck squamous cell carcinoma patients. Combination therapies promote higher pathologic response rates versus...
2.
Contrera K, Reddy P, Helou V, Myers J, Skinner H, Ferrarotto R, et al.
Laryngoscope
. 2025 Feb;
PMID: 39960134
Objective: The management of head and neck squamous cell carcinoma (HNSCC) has substantially changed over the past two centuries. This review explores the historical progression of HNSCC management focusing on...
3.
Wu E, Obuekwe F, Smith J, Solari M, Eguia A, Enoh T, et al.
Oral Oncol
. 2024 Nov;
160:107127.
PMID: 39603192
No abstract available.
4.
Contrera K, Spector M, Pantanowitz L, Abukhiran I, Vujanovic L, Whiteside T, et al.
JCO Precis Oncol
. 2024 Nov;
8():e2400183.
PMID: 39565979
CD8 tumor-infiltrating lymphocytes (TILs) are increasingly used in oncology as a prognostic and predictive tool to guide patient management. This review summarizes current literature on CD8 TILs in head and...
5.
Contrera K, Ferrarotto R, Gunn B, Su S, Kies M, Glisson B, et al.
Clin Cancer Res
. 2024 Nov;
31(2):258-265.
PMID: 39531535
Purpose: Outcomes after primary surgery for advanced sinonasal squamous cell carcinoma (SCC) are poor. We tested whether induction chemotherapy (IC) can improve disease control or organ preservation. Patients And Methods:...
6.
Brahimaj B, Contrera K, Rubino F, Almeida R, Ferrarotto R, Phan J, et al.
J Neurol Surg B Skull Base
. 2024 Nov;
85(6):650-658.
PMID: 39483161
The aim of this study was to investigate the safety of induction chemotherapy (IC) for patients with sinonasal malignancies with brain invasion or a neurological deficit. We conducted a retrospective...
7.
Harris M, Dang S, Smith J, Chinn S, Sridharan S, Contrera K, et al.
Oral Oncol
. 2024 Oct;
159:107076.
PMID: 39406013
Microvascular free flap surgery permits single-stage reconstruction of complex head and neck ablative defects. Venous congestion can occur in the early postoperative period, risking partial or total flap loss. While...
8.
Smith J, Smith B, Rosko A, Sridharan S, Contrera K, Heft-Neal M, et al.
Oral Oncol
. 2024 Oct;
159:107059.
PMID: 39384438
No abstract available.
9.
Smith J, Chinn S, Sridharan S, Contrera K, Heft-Neal M, Spector M
Otolaryngol Head Neck Surg
. 2024 Oct;
172(1):162-166.
PMID: 39353143
Objective: We describe a novel technique for endoscope-assisted (EA) transcervical (TC) approach for resection of parapharyngeal space (PPS) tumors and compare perioperative outcomes of this approach to standard TC approaches....
10.
Tang A, Dang S, Lao I, Pandya S, Solari M, Maxwell J, et al.
Am J Otolaryngol
. 2024 Aug;
45(6):104451.
PMID: 39137698
Objective: Malnutrition is an important risk factor for patient surgical outcomes. This is especially true for head and neck cancer (HNC) patients receiving a total laryngectomy with free flap reconstruction...